62 related articles for article (PubMed ID: 26402166)
1. Problems and pitfalls in grading of bone marrow fibrosis, collagen deposition and osteosclerosis - a consensus-based study.
Kvasnicka HM; Beham-Schmid C; Bob R; Dirnhofer S; Hussein K; Kreipe H; Kremer M; Schmitt-Graeff A; Schwarz S; Thiele J; Werner M; Stein H
Histopathology; 2016 May; 68(6):905-15. PubMed ID: 26402166
[TBL] [Abstract][Full Text] [Related]
2. Automated Osteosclerosis Grading of Clinical Biopsies Using Infrared Spectroscopic Imaging.
Mankar R; Bueso-Ramos CE; Yin CC; Hidalgo-Lopez JE; Berisha S; Kansiz M; Mayerich D
Anal Chem; 2020 Jan; 92(1):749-757. PubMed ID: 31793292
[TBL] [Abstract][Full Text] [Related]
3. Myeloproliferative neoplasms: Morphology and clinical practice.
Barbui T; Thiele J; Vannucchi AM; Tefferi A
Am J Hematol; 2016 Jun; 91(4):430-3. PubMed ID: 26718907
[TBL] [Abstract][Full Text] [Related]
4. The 2016 WHO classification and diagnostic criteria for myeloproliferative neoplasms: document summary and in-depth discussion.
Barbui T; Thiele J; Gisslinger H; Kvasnicka HM; Vannucchi AM; Guglielmelli P; Orazi A; Tefferi A
Blood Cancer J; 2018 Feb; 8(2):15. PubMed ID: 29426921
[TBL] [Abstract][Full Text] [Related]
5. Label-free quantification of imaging features in the extracellular matrix of left and right-sided colon cancer tissues.
Arora B; Kulkarni A; Markus MA; Ströbel P; Bohnenberger H; Alves F; Ramos-Gomes F
Sci Rep; 2024 Mar; 14(1):7510. PubMed ID: 38553551
[TBL] [Abstract][Full Text] [Related]
6. The Extracellular Niche and Tumor Microenvironment Enhance KRAS Inhibitor Efficacy in Pancreatic Cancer.
Kumarasamy V; Wang J; Frangou C; Wan Y; Dynka A; Rosenheck H; Dey P; Abel EV; Knudsen ES; Witkiewicz AK
Cancer Res; 2024 Apr; 84(7):1115-1132. PubMed ID: 38294344
[TBL] [Abstract][Full Text] [Related]
7. Quantitative interpretation of bone marrow biopsies in MPN-What's the point in a molecular age?
Ryou H; Lomas O; Theissen H; Thomas E; Rittscher J; Royston D
Br J Haematol; 2023 Nov; 203(4):523-535. PubMed ID: 37858962
[TBL] [Abstract][Full Text] [Related]
8. Progression in Myeloid Neoplasms: Beyond the Myeloblast.
Faria C; Tzankov A
Pathobiology; 2024; 91(1):55-75. PubMed ID: 37232015
[TBL] [Abstract][Full Text] [Related]
9. Safety and efficacy of zinpentraxin alfa as monotherapy or in combination with ruxolitinib in myelofibrosis: stage I of a phase II trial.
Verstovsek S; Foltz L; Gupta V; Hasserjian R; Manshouri T; Mascarenhas J; Mesa R; Pozdnyakova O; Ritchie E; Veletic I; Gamel K; Hamidi H; Han L; Higgins B; Trunzer K; Uguen M; Wang D; El-Galaly TC; Todorov B; Gotlib J
Haematologica; 2023 Oct; 108(10):2730-2742. PubMed ID: 37165840
[TBL] [Abstract][Full Text] [Related]
10. Cytological Diagnosis of Classic Myeloproliferative Neoplasms at the Age of Molecular Biology.
Combaluzier S; Quessada J; Abbou N; Arcani R; Tichadou A; Gabert J; Costello R; Loosveld M; Venton G; Berda-Haddad Y
Cells; 2023 Mar; 12(6):. PubMed ID: 36980287
[TBL] [Abstract][Full Text] [Related]
11. Characterizing the Bone Marrow Environment in Advanced-Stage Myelofibrosis during Ruxolitinib Treatment Using PET/CT and MRI: A Pilot Study.
Slot S; Lavini C; Zwezerijnen GJC; Boden BJH; Marcus JT; Huisman MC; Yaqub M; Barbé E; Wondergem MJ; Zijlstra JM; Zweegman S; Raijmakers PG
Tomography; 2023 Feb; 9(2):459-474. PubMed ID: 36960997
[TBL] [Abstract][Full Text] [Related]
12. Artificial Intelligence in Bone Marrow Histological Diagnostics: Potential Applications and Challenges.
van Eekelen L; Litjens G; Hebeda KM
Pathobiology; 2024; 91(1):8-17. PubMed ID: 36791682
[TBL] [Abstract][Full Text] [Related]
13. Myelofibrosis progression grading based on type I and type III collagen and fibrillin 1 expression boosted by whole slide image analysis.
Szekely T; Wichmann B; Maros ME; Csizmadia A; Bodor C; Timar B; Krenacs T
Histopathology; 2023 Mar; 82(4):622-632. PubMed ID: 36416374
[TBL] [Abstract][Full Text] [Related]
14. Tracking fibrosis in myeloproliferative neoplasms by CCR2 expression on CD34
Pozzi G; Carubbi C; Gobbi G; Tagliaferri S; Mirandola P; Vitale M; Masselli E
Front Oncol; 2022; 12():980379. PubMed ID: 36072806
[TBL] [Abstract][Full Text] [Related]
15. Correlations Between the Expression of Stromal Cell Activation Related Biomarkers, L-NGFR, Phospho-ERK1-2 and CXCL12, and Primary Myelofibrosis Progression.
Szekely T; Krenacs T; Maros ME; Bodor C; Daubner V; Csizmadia A; Vrabely B; Timar B
Pathol Oncol Res; 2022; 28():1610217. PubMed ID: 35356507
[TBL] [Abstract][Full Text] [Related]
16. Polarization Sensitive Photothermal Mid-Infrared Spectroscopic Imaging of Human Bone Marrow Tissue.
Mankar R; Gajjela CC; Bueso-Ramos CE; Yin CC; Mayerich D; Reddy RK
Appl Spectrosc; 2022 Apr; 76(4):508-518. PubMed ID: 35236126
[TBL] [Abstract][Full Text] [Related]
17. Disease Modification in Myelofibrosis: An Elusive Goal?
Vachhani P; Verstovsek S; Bose P
J Clin Oncol; 2022 Apr; 40(11):1147-1154. PubMed ID: 35084934
[No Abstract] [Full Text] [Related]
18. Transcriptomics reveals immune-metabolism disorder in acute-on-chronic liver failure in rats.
Hassan HM; Cai Q; Liang X; Xin J; Ren K; Jiang J; Shi D; Lu Y; Li T; Shang Y; He L; Chen X; Sun S; Li P; Guo B; Chen J; Yang H; Hu W; Chen X; Li J
Life Sci Alliance; 2022 Mar; 5(3):. PubMed ID: 34853163
[TBL] [Abstract][Full Text] [Related]
19. Progression in Ph-Chromosome-Negative Myeloproliferative Neoplasms: An Overview on Pathologic Issues and Molecular Determinants.
Sabattini E; Pizzi M; Agostinelli C; Bertuzzi C; Sagramoso Sacchetti CA; Palandri F; Gianelli U
Cancers (Basel); 2021 Nov; 13(21):. PubMed ID: 34771693
[TBL] [Abstract][Full Text] [Related]
20. Picrosirius Red Staining: Revisiting Its Application to the Qualitative and Quantitative Assessment of Collagen Type I and Type III in Tendon.
López De Padilla CM; Coenen MJ; Tovar A; De la Vega RE; Evans CH; Müller SA
J Histochem Cytochem; 2021 Oct; 69(10):633-643. PubMed ID: 34549650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
